Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate dated 7th October, 2020 issued by M/s. Purva Shregistey India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company confirming the compliances of regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020. Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of AGM
summary of the proceedings as required under Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations with respect to 26th Annual General Meeting of the company held on Friday, 16th October, 2020 at 2:00 PM till 3.00 PM at the registered office of the company situated at Plot No. 20, Survey No.52, Rajkot- Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Dist. Rajkot-360311, Gujarat. Parmax Pharma Ltd - 540359 - Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020.
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all activities in relation to both physical and electronic share transfer facility are maintained during the period of 1st April 2020 to 30th September, 2020 (both days inclusive) by the Company''s Registrar and Share Transfer Agent, i.e. M/s Purva Sharegistry India Pvt. Ltd., having its Office at Unit no. 9, Shiv Shakti Ind. Estt. J .R. Boricha Marg, Lower Parel (E), Mumbai 400 011. Further, we confirm that M/s Purva Sharegistry India Pvt. Ltd. is registered as Permanent Category- I Registrar and Transfer Agent with the Securities and Exchange Board of India (SEBI Registration no. INR000001112). Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH VORADesignation :- Company Secretary and Compliance Officer Parmax Pharma Ltd - 540359 - Closure of Trading Window
This is to inform you that pursuant to Company''s Code of Practices and Procedures and Code of Conduct to Regulate, Monitor and Report Trading in Securities and SEBI (Prohibition of Insider Trading) Regulations, 2015, ''Trading Window'' for dealing in securities of the Company for designated persons will remain closed with immediate effect till 48 hours after the declaration of financial results for the Quarter and half year ended on 30th September, 2020. The date of announcement of the financial results for the quarter and half year ended on 30th September, 2020 shall be announced in due course. Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement published in Financial Express (Gujarati & English Editions) dated. 26th September, 2020 intimating that the Annual General Meeting of the Company is scheduled to be convened on Friday, the 16th day of October, 2020 and providing of e-voting facility to all members through-voting platform of Central Depository Services (India) Limited . Thanking you, Parmax Pharma Ltd - 540359 - Reg. 34 (1) Annual Report
Submission of Annual Report for Financial Year 2019-20 and pursuant to Reg. 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Parmax Pharma Ltd - 540359 - Intimation Of Annual General Meeting, Book Closure And Cut-Off Date
Dear Sir/Madam, Kindly note that, i. The 26th Annual General Meeting ('AGM') of the 'Parmax Pharma Limited' ('the Company') is scheduled to be held on Friday, 16th October, 2020 at 2:00 P.M. at registered office of the company at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Rajkot - 360311. ii. The Register of Members and the Share Transfer Books of the Company will remain closed from 10th October, 2020 to 16th October, 2020 (both days inclusive). iii. The cut-off date for the purpose of e-voting will be on 9th October, 2020. Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Parmax Pharma Ltd - 540359 - Intimation Resumption Of Company'S Manufacturing Unit.
In continuation of our Corporate Announcement dated 25th August, 2020 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that Company has received the Final Order from the Deputy Collector and Sub Divisional Magistrate Rajkot City -2, and according to directives of final order dated 14.09.2020 competent authority has revoked the temporary closure of company's manufacturing activities. Hence, the Company has resumed its production activities in the unit. Kindly take this on your records.